Reversal of Metabolic and Neurological Symptoms of Phenylketonuric Mice Treated with a PAH Containing Helper-Dependent Adenoviral Vector

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|12|1|48-56

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.12, Iss.1, 2012-02, pp. : 48-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Helper-Dependent Adenoviral Vector Research

By  

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 222-235

Bentham Science Publishers

Access to resources Recommend Favorite

Liver-Directed Gene Therapy with Helper-Dependent Adenoviral Vectors: Current State of the Art and Future Challenges

By  

Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. : 2488-2499

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Response to Helper Dependent Adenoviral Mediated Liver Gene Therapy: Challenges and Prospects

By  

Current Gene Therapy, Vol. 7, Iss. 5, 2007-10 ,pp. : 297-305

Bentham Science Publishers

Access to resources Recommend Favorite

Progress Towards Liver and Lung-Directed Gene Therapy with Helper- Dependent Adenoviral Vectors

By  

Current Gene Therapy, Vol. 9, Iss. 5, 2009-10 ,pp. : 329-340

Bentham Science Publishers

Access to resources Recommend Favorite

Modification by Muscimol of Naloxone-precipitated Withdrawal Symptoms in Morphine-dependent Mice

By El-Kadi A.O.S.   Sharif S.I.  

General Pharmacology, Vol. 26, Iss. 7, 1995-11 ,pp. : 1579-1581

Elsevier

Access to resources Recommend Favorite